Effects of Kojic Acid-mediated Sonodynamic Therapy as a Matrix
Metalloprotease-9 Inhibitor against Oral Squamous Cell Carcinoma: A
Bioinformatics Screening and In Vitro Analysis

Maryam      Pourhajibagher; Mojgan      Alaeddini; Shahroo      Etemad-Moghadam; Steven      Parker; Abbas      Bahador

doi:10.2174/0115701638266082231124055825

Abstract

Background: Oral squamous cell carcinoma (OSCC) is a type of cancer that is responsible for a significant amount of morbidity and mortality worldwide. Researchers are searching for promising therapeutic methods to manage this cancer. In this study, an in silico approach was used to evaluate the activity of sonodynamic therapy (SDT) based on the use of Kojic acid as a sonosensitizer to inhibit matrix metalloprotease-9 (MMP-9) in OSCC.

Materials and Methods: The three-dimensional structure of MMP-9 was predicted and validated by computational approaches. The possible functional role of MMP-9 was determined in terms of Gene Ontology (GO) enrichment analysis. In silico, molecular docking was then performed to evaluate the binding energies of Kojic acid with MMP-9, and ADME parameters and toxicity risks were predicted. The pharmacokinetics and drug-likeness properties of Kojic acid were assessed. Moreover, after the determination of the cytotoxicity effect of Kojic acid-mediated SDT, the change of mmp-9 gene expression was assessed on OSCC cells.

Results: The results of the study showed that Kojic acid could efficiently interact with MMP-9 protein with a strong binding affinity. Kojic acid obeyed Lipinski’s rule of five without violation and exhibited drug-likeness. The cytotoxic effects of Kojic acid and ultrasound waves on the OSCC cells were dose-dependent, and the lowest expression level of the mmp-9 gene was observed in SDT.

Conclusions: Overall, Kojic acid-mediated SDT as an MMP-9 inhibitor can be a promising adjuvant treatment for OSCC. The study highlights the potential of In silico approaches to evaluate therapeutic methods for cancer treatment.

Graphical Abstract

[1]
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers  2020; 6(1): 92.
 [http://dx.doi.org/10.1038/s41572-020-00224-3] [PMID:  33243986]

[2]
Marur S, Forastiere AA. Head and neck squamous cell carcinoma: Update on epidemiology, diagnosis, and treatment. Mayo Clin Proc  2016; 91(3): 386-96.
 [http://dx.doi.org/10.1016/j.mayocp.2015.12.017] [PMID:  26944243]

[3]
Shay G, Lynch CC, Fingleton B. Moving targets: Emerging roles for MMPs in cancer progression and metastasis. Matrix Biol  2015; 44-46: 200-6.
 [http://dx.doi.org/10.1016/j.matbio.2015.01.019] [PMID:  25652204]

[4]
Bates AM, Gomez Hernandez MP, Lanzel EA, Qian F, Brogden KA. Matrix metalloproteinase (MMP) and immunosuppressive biomarker profiles of seven head and neck squamous cell carcinoma (HNSCC) cell lines. Transl Cancer Res  2018; 7(3): 533-42.
 [http://dx.doi.org/10.21037/tcr.2018.05.09] [PMID:  30221145]

[5]
Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol  2000; 10(6): 415-33.
 [http://dx.doi.org/10.1006/scbi.2000.0379] [PMID:  11170864]

[6]
Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer  2002; 2(3): 161-74.
 [http://dx.doi.org/10.1038/nrc745] [PMID:  11990853]

[7]
Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia  2001; 3(6): 459-68.
 [http://dx.doi.org/10.1038/sj.neo.7900190] [PMID:  11774028]

[8]
DeClerck YA, Mercurio AM, Stack MS, et al. Proteases, extracellular matrix, and cancer: A workshop of the path B study section. Am J Pathol  2004; 164(4): 1131-9.
 [http://dx.doi.org/10.1016/S0002-9440(10)63200-2] [PMID:  15039201]

[9]
Khokha R, Murthy A, Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol  2013; 13(9): 649-65.
 [http://dx.doi.org/10.1038/nri3499] [PMID:  23969736]

[10]
Vilen ST, Salo T, Sorsa T, Nyberg P. Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma. ScientificWorldJournal  2013; 2013: 1-11.
 [http://dx.doi.org/10.1155/2013/920595] [PMID:  23365550]

[11]
Lِffek S, Schilling O, Franzke CW. Biological role of matrix metalloproteinases: A critical balance. Eur Respir J  2011; 38(1): 191-208.
 [http://dx.doi.org/10.1183/09031936.00146510] [PMID:  21177845]

[12]
Iizuka S, Ishimaru N, Kudo Y. Matrix metalloproteinases: The gene expression signatures of head and neck cancer progression. Cancers  2014; 6(1): 396-415.
 [http://dx.doi.org/10.3390/cancers6010396] [PMID:  24531055]

[13]
Patel BP, Shah SV, Shukla SN, Shah PM, Patel PS. Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck  2007; 29(6): 564-72.
 [http://dx.doi.org/10.1002/hed.20561] [PMID:  17252594]

[14]
Zilles JC, dos Santos FL, Kulkamp-Guerreiro IC, Contri RV. Biological activities and safety data of kojic acid and its derivatives: A review. Exp Dermatol  2022; 31(10): 1500-21.
 [http://dx.doi.org/10.1111/exd.14662] [PMID:  35960194]

[15]
Oncul S, Karakaya G, Dilsiz Aytemir M, Ercan A. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance. Chem Biol Drug Des  2019; 94(6): 2084-93.
 [http://dx.doi.org/10.1111/cbdd.13615] [PMID:  31495064]

[16]
Karakaya G, Ercan A, Oncul S, Aytemir MD. Synthesis and cytotoxic evaluation of kojic acid derivatives with inhibitory activity on melanogenesis in human melanoma cells. Anticancer Agents Med Chem  2019; 18(15): 2137-48.
 [http://dx.doi.org/10.2174/1871520618666180402141714] [PMID:  29607787]

[17]
Ercan A, Oncul S, Karakaya G, Aytemir M. An allomaltol derivative triggers distinct death pathways in luminal a and triple-negative breast cancer subtypes. Bioorg Chem  2020; 105: 104403.
 [http://dx.doi.org/10.1016/j.bioorg.2020.104403] [PMID:  33166845]

[18]
Annan NA, Butler IS, Titi HM, El-Lazeik Y, Jean-Claude BJ, Mostafa SI. DNA interaction and anticancer evaluation of new zinc(II), ruthenium(II), rhodium(III), palladium(II), silver(I) and platinum(II) complexes based on kojic acid; X-ray crystal structure of [Ag(ka)(PPh3)]·H2O. Inorg Chim Acta  2019; 487: 433-47.
 [http://dx.doi.org/10.1016/j.ica.2018.12.031]

[19]
Momo CHK, Mboussaah ADK, François ZN, Shaiq MA. New pyran derivative with antioxidant and anticancer properties isolated from the probiotic Lactobacillus plantarum H24 strain. Nat Prod Res  2022; 36(4): 909-17.
 [http://dx.doi.org/10.1080/14786419.2020.1849201] [PMID:  33225751]

[20]
Nawarak J, Huang-Liu R, Kao SH, et al. Proteomics analysis of kojic acid treated A375 human malignant melanoma cells. J Proteome Res  2008; 7(9): 3737-46.
 [http://dx.doi.org/10.1021/pr7008737] [PMID:  18630942]

[21]
Cheng SL, Huang Liu R, Sheu JN, Chen ST, Sinchaikul S, Tsay GJ. Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull  2006; 29(4): 655-69.
 [http://dx.doi.org/10.1248/bpb.29.655] [PMID:  16595896]

[22]
El-Metwally MM, ElBealy ER, Beltagy DM, Shaaban M, El-kott AF. Suppressive efficiency of Kojic acid from Aspergillus tamarii MM11 against HepG-2 cell line derived from human liver cancer. Trop J Pharm Res  2020; 19(8): 1661-8.
 [http://dx.doi.org/10.4314/tjpr.v19i8.14]

[23]
Moon KY, Ahn KS, Lee J, Kim YS. Kojic acid, a potential inhibitor of NF-κB activation in transfectant human HaCaT and SCC-13 cells. Arch Pharm Res  2001; 24(4): 307-11.
 [http://dx.doi.org/10.1007/BF02975097] [PMID:  11534762]

[24]
Gomes AJ, Lunardi CN, Gonzalez S, Tedesco AC. The antioxidant action of Polypodium leucotomos extract and kojic acid: Reactions with reactive oxygen species. Braz J Med Biol Res  2001; 34(11): 1487-94.
 [http://dx.doi.org/10.1590/S0100-879X2001001100018] [PMID:  11668361]

[25]
Rho HS, Ahn SM, Yoo DS, Kim MK, Cho DH, Cho JY. Kojyl thioether derivatives having both tyrosinase inhibitory and anti-inflammatory properties. Bioorg Med Chem Lett  2010; 20(22): 6569-71.
 [http://dx.doi.org/10.1016/j.bmcl.2010.09.042] [PMID:  20934336]

[26]
Dung TTM, Kim SC, Yoo BC, et al. (5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl 6-hydroxynaphthalene-2-carboxylate, a kojic acid derivative, inhibits inflammatory mediator production via the suppression of Syk/Src and NF-κB activation. Int Immunopharmacol  2014; 20(1): 37-45.
 [http://dx.doi.org/10.1016/j.intimp.2014.02.019] [PMID:  24583147]

[27]
Khan A, Park TJ, Ikram M, et al. Antioxidative and anti-inflammatory effects of kojic acid in aβ-induced mouse model of alzheimer’s disease. Mol Neurobiol  2021; 58(10): 5127-40.
 [http://dx.doi.org/10.1007/s12035-021-02460-4] [PMID:  34255249]

[28]
Gao G, Liu F, Xu Z, et al. Evidence of nigericin as a potential therapeutic candidate for cancers: A review. Biomed Pharmacother  2021; 137: 111262.
 [http://dx.doi.org/10.1016/j.biopha.2021.111262] [PMID:  33508621]

[29]
Ramsay D, Stevenson H, Jerjes W. From basic mechanisms to clinical research: Photodynamic therapy applications in head and neck malignancies and vascular anomalies. J Clin Med  2021; 10(19): 4404.
 [http://dx.doi.org/10.3390/jcm10194404] [PMID:  34640423]

[30]
Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol  2020; 17(11): 657-74.
 [http://dx.doi.org/10.1038/s41571-020-0410-2] [PMID:  32699309]

[31]
Gheewala T, Skwor T, Munirathinam G. Photosensitizers in prostate cancer therapy. Oncotarget  2017; 8(18): 30524-38.
 [http://dx.doi.org/10.18632/oncotarget.15496] [PMID:  28430624]

[32]
Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: An update. CA Cancer J Clin  2011; 61(4): 250-81.
 [http://dx.doi.org/10.3322/caac.20114] [PMID:  21617154]

[33]
Gao J, Chen Z, Li X, et al. Chemiluminescence in combination with organic photosensitizers: Beyond the light penetration depth limit of photodynamic therapy. Int J Mol Sci  2022; 23(20): 12556.
 [http://dx.doi.org/10.3390/ijms232012556] [PMID:  36293406]

[34]
Jiang Z, Yang X, Ainiwaer M, Chen F, Liu J. Recent clinical and preclinical advances in external stimuli-responsive therapies for head and neck squamous cell carcinoma. J Clin Med  2022; 12(1): 173.
 [http://dx.doi.org/10.3390/jcm12010173] [PMID:  36614974]

[35]
Pourhajibagher M, Bahador A. In vitro application of sonodynamic antimicrobial chemotherapy as a sonobactericidal therapeutic approach for bacterial infections: A systematic review and meta-analysis. J Lasers Med Sci  2020; 11(S1): S1-7.
 [http://dx.doi.org/10.34172/jlms.2020.S1] [PMID:  33995962]

[36]
Pourhajibagher M, Bahador A. Virtual screening and computational simulation analysis of antimicrobial photodynamic therapy using propolis-benzofuran A to control of Monkeypox. Photodiagn Photodyn Ther  2023; 41: 103208.
 [http://dx.doi.org/10.1016/j.pdpdt.2022.103208] [PMID:  36417972]

[37]
Pourhajibagher M. Molecular modeling and simulation analysis of antimicrobial photodynamic therapy potential for control of COVID-19. ScientificWorldJournal  2022; 2022: 1-11.
 [http://dx.doi.org/10.1155/2022/7089576] [PMID:  35685718]

[38]
Bahador A, Pourhajibagher M. Molecular docking study of potential antimicrobial photodynamic therapy as a potent inhibitor of SARS-CoV-2 main protease: An in silico insight. Infect Disord Drug Targets  2023; 23(2): e010922208438.
 [http://dx.doi.org/10.2174/1871526522666220901164329] [PMID:  36056873]

[39]
Sliwoski G, Kothiwale S, Meiler J, Lowe EW Jr. Computational methods in drug discovery. Pharmacol Rev  2014; 66(1): 334-95.
 [http://dx.doi.org/10.1124/pr.112.007336] [PMID:  24381236]

[40]
Salmaso V, Moro S. Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview. Front Pharmacol  2018; 9: 923.
 [http://dx.doi.org/10.3389/fphar.2018.00923] [PMID:  30186166]

[41]
Özten Ö, Kuznetsov AE, Gokce M, et al. Assessing cytotoxic activities, theoretical and in silico molecular docking calculations of phthalocyanines bearing cinnamyloxy-groups.  J Biomol Struct Dyn  2023; 1-11.
 [http://dx.doi.org/10.1080/07391102.2023.2265503] [PMID:  37794772]

[42]
Pourhajibagher M, Bazarjani F, Bahador A. In silico and in vitro insights into the prediction and analysis of natural photosensitive compounds targeting Acinetobacter baumannii biofilm-associated protein. Photodiagn Photodyn Ther  2022; 40: 103134.
 [http://dx.doi.org/10.1016/j.pdpdt.2022.103134] [PMID:  36240659]

[43]
Wang J, Yu H, Ye L, Jin L, Yu M, Lv Y. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer. Int J Clin Exp Pathol  2015; 8(1): 517-29.
 [PMID:  25755742]

[44]
Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: Quality-controlled protein–protein association networks, made broadly accessible. Nucleic Acids Res  2017; 45(D1): D362-8.
 [http://dx.doi.org/10.1093/nar/gkw937] [PMID:  27924014]

[45]
Lipinski CA. Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov Today Technol  2004; 1(4): 337-41.
 [http://dx.doi.org/10.1016/j.ddtec.2004.11.007] [PMID:  24981612]

[46]
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc  2008; 3(6): 1101-8.
 [http://dx.doi.org/10.1038/nprot.2008.73] [PMID:  18546601]

[47]
Alam M, Abbasi K, Nouri F, et al. The cytotoxicity and anticancer effects of propolis against the oral squamous cell carcinoma: In vitro study. Open Access Maced J Med Sci  2022; 10: 2374-81.

[48]
Park JS, Park S, Park SJ, Kim SK. Synergistic effects of concurrent photodynamic therapy with indocyanine green and chemotherapy in Hepatocellular Carcinoma cell lines and mouse models. J Photochem Photobiol B  2023; 239: 112642.
 [http://dx.doi.org/10.1016/j.jphotobiol.2022.112642] [PMID:  36623346]

[49]
Hajmohammadi E, Molaei T, Mowlaei SH, et al. Sonodynamic therapy and common head and neck cancers: In vitro and in vivo studies. Eur Rev Med Pharmacol Sci  2021; 25(16): 5113-21.
 [http://dx.doi.org/10.26355/eurrev_202108_26522] [PMID:  34486685]

[50]
Klausen M, Ucuncu M, Bradley M. Design of photosensitizing agents for targeted antimicrobial photodynamic therapy. Molecules  2020; 25(22): 5239.
 [http://dx.doi.org/10.3390/molecules25225239] [PMID:  33182751]

[51]
Abrahamse H, Hamblin MR. New photosensitizers for photodynamic therapy. Biochem J  2016; 473(4): 347-64.
 [http://dx.doi.org/10.1042/BJ20150942] [PMID:  26862179]

[52]
Ashburner M, Ball CA, Blake JA, et al. Gene Ontology: Tool for the unification of biology. Nat Genet  2000; 25(1): 25-9.
 [http://dx.doi.org/10.1038/75556] [PMID:  10802651]

[53]
Thomas PD. The gene ontology and the meaning of biological function. Methods Mol Biol  2017; 1446: 15-24.
 [http://dx.doi.org/10.1007/978-1-4939-3743-1_2] [PMID:  27812932]

[54]
Lewis SE. The vision and challenges of the gene ontology. Methods Mol Biol  2017; 1446: 291-302.
 [http://dx.doi.org/10.1007/978-1-4939-3743-1_21] [PMID:  27812951]

[55]
Saeedi M, Eslamifar M, Khezri K. Kojic acid applications in cosmetic and pharmaceutical preparations. Biomed Pharmacother  2019; 110: 582-93.
 [http://dx.doi.org/10.1016/j.biopha.2018.12.006] [PMID:  30537675]

[56]
Yoo DS, Lee J, Choi SS, et al. A modulatory effect of novel kojic acid derivatives on cancer cell proliferation and macrophage activation. Pharmazie  2010; 65(4): 261-6.
 [PMID:  20432622]

[57]
Szakács G, Váradi A, Özvegy-Laczka C, Sarkadi B. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME–Tox). Drug Discov Today  2008; 13(9-10): 379-93.
 [http://dx.doi.org/10.1016/j.drudis.2007.12.010] [PMID:  18468555]

[58]
Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep  2017; 7(1): 42717.
 [http://dx.doi.org/10.1038/srep42717] [PMID:  28256516]

[59]
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev  2001; 46(1-3): 3-26.
 [http://dx.doi.org/10.1016/S0169-409X(00)00129-0] [PMID:  11259830]

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/0115701638266082231124055825	Print ISSN 1570-1638
Publisher Name Bentham Science Publisher	Online ISSN 1875-6220

Current Drug Discovery Technologies

Effects of Kojic Acid-mediated Sonodynamic Therapy as a Matrix Metalloprotease-9 Inhibitor against Oral Squamous Cell Carcinoma: A Bioinformatics Screening and In Vitro Analysis

Abstract Play Pause

Graphical Abstract

Related Journals

Related Books

Abstract